Pro-convulsant effects: A neglected dimension of psychotropic activity

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 11, 2013, Pages 998-1001

  Atigari, Onome ^a   Healy, David ^a  

^a YSBYTY GWYNEDD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; BEMEGRIDE; BENZODIAZEPINE; CAMPHOR; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CLOZAPINE; FLUOROETHYL; GLYX 13; GLYX13; KETAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PENTETRAZOLE; PICROTOXIN; PSYCHOTROPIC AGENT; QUETIAPINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VALPROIC ACID;

AGRANULOCYTOSIS; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ANTIDEPRESSANT ACTIVITY; ATTENTION DEFICIT DISORDER; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CATATONIA; CHILDHOOD DISEASE; CONVULSION; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; KINDLING; MENTAL HEALTH; NOTE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEROTONINERGIC SYSTEM; SIDE EFFECT; TRANQUILIZING ACTIVITY; TREATMENT RESISTANT DEPRESSION;

CONVULSANTS; HUMANS; MENTAL DISORDERS; PSYCHOTROPIC DRUGS;

EID: 84887482790     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867413495469     Document Type: Note

References (15)

1. Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: A new treatment. American Journal of Psychiatry. 1980 ; 137: 782-790
2. Berman RM, Capiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry. 2000 ; 47: 351-354
3. Braga R, Petrides G. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. Journal of ECT. 2005 ; 21: 75-83
4. Burgdorf J, Zhang X, Nicholson KL, et al. GLYX-13, an NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology. 2013 ; 38: 729-742
5. Claridge G Drugs and Human Behaviour. London: Penguin Books ; 1972:
6. Claridge G The Psychopharmacologists. Healy D, ed. London, Arnold, London: ; 1996: 441-462.
7. Eysenck HJ Experiments with Drugs. London: Pergamon Press ; 1963:
8. Harris M, Chandran S, Chakroborty N, et al. Mood stabilizers: the archaeology of the concept. Bipolar Disorders. 2003 ; 5: 446-452
9. Healy D The Creation of Psychopharmacology. Cambridge, MA: Harvard University Press ; 2002: 63-66.
10. Healy D Mania. A Short History of Bipolar Disorder. Baltimore, MD: Johns Hopkins University Press ; 2008: 198-218.
11. Murrough JW. Ketamine as a novel antidepressant: From synapse to behavior. Clinical Pharmacology & Therapeutics. 2012 ; 91: 303-309
12. Post RM The Triumph of Psychopharmacology and the Story of CINP. Ban TA Healy D Shorter E, ed. Budapest: Animula Publishing ; 2000: 296-299.
13. Post RM, Rubinow D, Ballenger JC. Conditioning and sensitization in the longitudinal course of affective illness. British Journal of Psychiatry. 1986 ; 149: 191-201
14. Silberman EK, Post RM, Nurnberger J, et al. Transient sensory, cognitive and affective phenomena in affective illness. A comparison with complex partial epilepsy. British Journal of Psychiatry. 1985 ; 146: 81-89
15. Zarate CA, Matthews D, Ibrahim L, et al. A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression. Biological Psychiatry. 2012 2012 ;: